These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26883693)

  • 1. Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents.
    Gonzalez D; Palazzi DL; Bhattacharya-Mithal L; Al-Uzri A; James LP; Bradley J; Neu N; Jasion T; Hornik CP; Smith PB; Benjamin DK; Keedy K; Fernandes P; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2572-6. PubMed ID: 26883693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
    Still JG; Schranz J; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ; Clark K
    Antimicrob Agents Chemother; 2011 May; 55(5):1997-2003. PubMed ID: 21282444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Dried Blood Spot Analysis for Solithromycin in Adolescents, Children, and Infants: A Short Communication.
    Beechinor RJ; Cohen-Wolkowiez M; Jasion T; Hornik CP; Lang JE; Hernandez R; Gonzalez D
    Ther Drug Monit; 2019 Dec; 41(6):761-765. PubMed ID: 31318840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.
    Gonzalez D; James LP; Al-Uzri A; Bosheva M; Adler-Shohet FC; Mendley SR; Bradley JS; Espinosa C; Tsonkova E; Moffett K; Marquez L; Simonsen KA; Stoilov S; Boakye-Agyeman F; Jasion T; Hornik CP; Hernandez R; Benjamin DK; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
    Salerno SN; Edginton A; Cohen-Wolkowiez M; Hornik CP; Watt KM; Jamieson BD; Gonzalez D
    CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):814-822. PubMed ID: 29068158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment.
    Jamieson BD; Ciric S; Fernandes P
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4379-86. PubMed ID: 25870056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
    Rodvold KA; Gotfried MH; Still JG; Clark K; Fernandes P
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5076-81. PubMed ID: 22802254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, Excretion, and Mass Balance of Solithromycin in Humans.
    MacLauchlin C; Schneider SE; Keedy K; Fernandes P; Jamieson BD
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection Model.
    Okusanya OO; Forrest A; Bhavnani SM; Fernandes P; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
    Salerno SN; Carreño FO; Edginton AN; Cohen-Wolkowiez M; Gonzalez D
    Drug Metab Dispos; 2021 Sep; 49(9):844-855. PubMed ID: 34154994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model.
    Keelan JA; Kemp MW; Payne MS; Johnson D; Stock SJ; Saito M; Fernandes P; Newnham JP
    Antimicrob Agents Chemother; 2014; 58(1):447-54. PubMed ID: 24189250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
    Oldach D; Clark K; Schranz J; Das A; Craft JC; Scott D; Jamieson BD; Fernandes P
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2526-34. PubMed ID: 23507282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA;
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.
    Zhanel GG; Hartel E; Adam H; Zelenitsky S; Zhanel MA; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty AJ; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2016 Dec; 76(18):1737-1757. PubMed ID: 27909995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solithromycin: A novel ketolide antibiotic.
    Buege MJ; Brown JE; Aitken SL
    Am J Health Syst Pharm; 2017 Jun; 74(12):875-887. PubMed ID: 28432048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the Solithromycin International Surveillance Program (2014).
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3662-8. PubMed ID: 27044551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
    Bradley JS; Benziger D; Bokesch P; Jacobs R
    Pediatr Infect Dis J; 2014 Sep; 33(9):936-9. PubMed ID: 25361023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs.
    Wyns H; Meyer E; Plessers E; Watteyn A; De Baere S; De Backer P; Croubels S
    Res Vet Sci; 2014 Feb; 96(1):160-3. PubMed ID: 24331716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
    Shi J; Montay G; Chapel S; Hardy P; Barrett JS; Sack M; Marbury T; Swan SK; Vargas R; Leclerc V; Leroy B; Bhargava VO
    J Clin Pharmacol; 2004 Mar; 44(3):234-44. PubMed ID: 14973302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.